Insider Selling: HCA Healthcare (NYSE:HCA) SVP Sells 3,500 Shares of Company Stock

HCA Healthcare, Inc. (NYSE:HCA) SVP Erica Rossitto sold 3,500 shares of the stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $505.81, for a total transaction of $1,770,335.00. Following the completion of the sale, the senior vice president directly owned 13,426 shares of the company’s stock, valued at $6,791,005.06. The trade was a 20.68% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

HCA Healthcare Stock Performance

Shares of NYSE:HCA traded down $0.62 during midday trading on Tuesday, hitting $504.27. 1,088,555 shares of the company’s stock traded hands, compared to its average volume of 1,352,859. The firm’s fifty day moving average price is $445.41 and its two-hundred day moving average price is $445.45. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The company has a market cap of $105.34 billion, a PE ratio of 16.71, a P/E/G ratio of 1.71 and a beta of 1.11.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.65 by $0.57. The firm had revenue of $19.85 billion during the quarter, compared to the consensus estimate of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The firm’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.96 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 30.15 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Tuesday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.34%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Jefferies Financial Group set a $450.00 price target on HCA Healthcare in a report on Tuesday, July 14th. Weiss Ratings upgraded shares of HCA Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. JPMorgan Chase & Co. reduced their target price on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating on the stock in a research report on Thursday, August 20th. Deutsche Bank Aktiengesellschaft set a $476.00 target price on shares of HCA Healthcare in a research note on Monday, July 27th. Finally, Oppenheimer lowered their price target on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a report on Monday, July 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $480.13.

Institutional Investors Weigh In On HCA Healthcare

Hedge funds have recently bought and sold shares of the business. BlackRock Inc. acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at approximately $5,069,974,000. Wellington Management Group LLP grew its position in shares of HCA Healthcare by 20.5% during the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after buying an additional 799,761 shares in the last quarter. Darsana Capital Partners LP increased its stake in shares of HCA Healthcare by 46.7% in the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock worth $428,879,000 after buying an additional 350,000 shares during the last quarter. Legal & General Group Plc acquired a new stake in HCA Healthcare in the second quarter valued at $410,992,000. Finally, Jupiter Topco LLC bought a new position in HCA Healthcare during the 2nd quarter valued at $371,138,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.